Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AGY Therapeutics licenses sigma receptor agonist compound from M's Science

July 22, 2004

NeuroSearch initiates phase II studies of NS-1209 for refractory status epilepticus

July 22, 2004

Transdermal lidocaine for the treatment of neuropathic sensory loss

July 21, 2004

Novel PARP inhibitors for the treatment of cerebral infarction

July 21, 2004

Novel therapeutic polyagent for Alzheimer's disease therapy

July 21, 2004

LY-411575 tested in novel animal model of Alzheimer's

July 21, 2004

Therapeutic benefits of mitoxantrone in multiple sclerosis

July 21, 2004

Preclinical efficacy in a task sensitive to Alzheimer's disease

July 20, 2004

Safinamide improves motor function in patients with Parkinson's disease

July 20, 2004

First phase of topical ENT-103 formulation completed

July 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...